Jeremy Grantham Gsk PLC Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $59.5 Million - $67.6 Million	1,415,300 Added 265.68%	1,948,000 $84.8 Million
Q1 2022 May 13, 2022	BUY	$40.23 - $47.74 $12 Million - $14.3 Million	298,600 Added 127.55%	532,700 $23.2 Million
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $2.13 Million - $2.48 Million	-54,800 Reduced 18.97%	234,100 $10.3 Million
Q3 2021 Nov 12, 2021	SELL	$38.79 - $43.16 $11.8 Million - $13.2 Million	-304,900 Reduced 51.35%	288,900 $11 Million
Q2 2021 Aug 12, 2021	BUY	$36.52 - $41.46 $12.9 Million - $14.6 Million	352,200 Added 145.78%	593,800 $23.6 Million
Q1 2021 May 13, 2021	BUY	$34.27 - $40.01 $6.94 Million - $8.1 Million	202,500 Added 517.9%	241,600 $8.62 Million
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $47,698 - $55,916	1,400 Added 3.71%	39,100 $1.44 Million
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $3.28 Million - $3.7 Million	-86,100 Reduced 69.55%	37,700 $1.42 Million
Q2 2020 Aug 13, 2020	SELL	$37.87 - $43.58 $12.7 Million - $14.7 Million	-336,600 Reduced 73.11%	123,800 $5.05 Million
Q1 2020 May 14, 2020	BUY	$32.47 - $48.83 $8.57 Million - $12.9 Million	263,900 Added 134.3%	460,400 $17.4 Million
Q4 2019 Feb 13, 2020	SELL	$42.0 - $48.25 $24.2 Million - $27.8 Million	-576,532 Reduced 74.58%	196,500 $9.23 Million
Q3 2019 Nov 13, 2019	SELL	$40.46 - $43.52 $53.8 Million - $57.9 Million	-1,330,400 Reduced 63.25%	773,032 $33 Million
Q2 2019 Aug 13, 2019	SELL	$39.4 - $42.7 $13.9 Million - $15.1 Million	-353,700 Reduced 14.39%	2,103,432 $84.2 Million
Q1 2019 May 14, 2019	SELL	$38.57 - $42.69 $1.78 Million - $1.97 Million	-46,200 Reduced 1.85%	2,457,132 $103 Million
Q4 2018 Feb 13, 2019	BUY	$37.8 - $42.69 $2.67 Million - $3.02 Million	70,700 Added 2.91%	2,503,332 $95.7 Million
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $28.8 Million - $31 Million	725,632 Added 42.51%	2,432,632 $97.7 Million
Q2 2018 Aug 14, 2018	BUY	$39.61 - $42.76 $7.78 Million - $8.39 Million	196,300 Added 12.99%	1,707,000 $68.8 Million
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $16.1 Million - $17.9 Million	446,000 Added 41.89%	1,510,700 $59 Million
Q4 2017 Feb 14, 2018	BUY	$35.34 - $41.9 $8.37 Million - $9.92 Million	236,800 Added 28.6%	1,064,700 $37.8 Million
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $20.6 Million - $21.7 Million	523,100 Added 171.62%	827,900 $33.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	304,800	304,800 $13.1 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account